Home > News > Nanogen Awarded $2.5 Million Grant
August 1st, 2005
Nanogen Awarded $2.5 Million Grant
Abstract:
Nanogen, Inc., developer of advanced diagnostic products, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health (NIH) has awarded the company a grant in the amount of $2.5 million over the next five years for a research project to develop a prototype fully integrated diagnostic system for clinical labs to identify infectious agents that cause sepsis and community-acquired pneumonia (CAP). The grant will enable Nanogen to develop improved molecular biological methods, miniaturize those methods, and demonstrate the performance of this new molecular diagnostic approach to diagnose sepsis and CAP in a hospital laboratory setting.
Source:
Nanogen
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||